Nexalin Technology (NXL) Other financing activities (2021 - 2026)
Nexalin Technology's quarterly Other financing activities came in at $478611.0 in Q1 2026, down 24.85% year-on-year from $636844.0 in Q1 2025, and down 42.44% quarter-over-quarter from $831529.0 in Q4 2025.
Nexalin Technology has reported Other financing activities for 6 years, with the latest figure at $478611.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 24.85% year-over-year to $478611.0; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (down 26.54% YoY), and the FY2025 full-year result was $3.1 million, down 12.28% from the prior year.
- Other financing activities for Q1 2026 stood at $478611.0, down from $831529.0 in the prior quarter.
- The five-year high for Other financing activities was $1.6 million in Q3 2023, with the low at -$182721.0 in Q4 2022.
- Average Other financing activities over 5 years is $606307.4, with a median of $478611.0 recorded in 2026.
- Year-over-year, Other financing activities plunged 269.97% in 2022 and soared 753.63% in 2023.
- Tracing NXL's Other financing activities over 5 years: stood at -$182721.0 in 2022, then jumped by 960.97% to $1.6 million in 2023, then slipped by 1.36% to $1.6 million in 2024, then tumbled by 46.41% to $831529.0 in 2025, then plunged by 42.44% to $478611.0 in 2026.
- The last three Other financing activities figures came in at $478611.0 (Q1 2026), $831529.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 478,611.00 |
| Mar 31, 2026 | 478,611.00 |
| Dec 31, 2025 | 831,529.00 |
| Dec 31, 2025 | 831,529.00 |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 572,100.00 |
| Jun 30, 2025 | 572,100.00 |
| Mar 31, 2025 | 636,844.00 |
| Mar 31, 2025 | 636,844.00 |
| Dec 31, 2024 | 1.55 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 308,283.00 |
| Jun 30, 2024 | 308,283.00 |
| Mar 31, 2024 | 161,349.00 |
| Mar 31, 2024 | 161,349.00 |
| Sep 30, 2023 | 1.57 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 88,388.00 |
| Jun 30, 2023 | 88,388.00 |
| Dec 31, 2022 | -182,721.00 |
| Dec 31, 2022 | -182,721.00 |
| Sep 30, 2022 | 184,291.00 |
| Sep 30, 2022 | 184,291.00 |
| Jun 30, 2022 | 171,600.00 |
| Jun 30, 2022 | 171,600.00 |
| Mar 31, 2022 | 97,500.00 |
| Mar 31, 2022 | 97,500.00 |
| Dec 31, 2021 | 107,502.00 |
| Dec 31, 2021 | 107,502.00 |
| Sep 30, 2021 | 1.49 Mn |
| Sep 30, 2021 | 1.49 Mn |